Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
EUDA Health Holdings Limited Announces Receipt of Nasdaq Listing Delinquency Letter 2023-05-20 04:05
Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES' 2023-05-20 00:55
Positive Results from Interim Analysis of 'GEN-001' Plus avelumab (Bavencio®) Phase II Trial 2023-05-19 21:00
Health In Tech Partners with Health Direct Partners to provide self-funded employer groups with full plan transparency, savings, and improved employee health. 2023-05-19 20:30
2023 Qingdao∙ Global Venture Capital Conference Comes to a Close 2023-05-19 20:00
Daewoong Pharmaceutical Presents New Clinical Data of Fexuprazan at Digestive Disease Week 2023 2023-05-19 20:00
The 133rd Canton Fair Gathers Top Medical Equipment to Unlock the Health Code 2023-05-19 19:49
HanAll Biopharma Announces Results from Phase III randomized, double-masked active treatment-controlled VELOS-3 Trial Evaluating Tanfanercept 0.25% for Treatment of Dry Eye Disease 2023-05-19 19:00
ExoCoBio obtained a US Patent for Rose Stem Cell-derived Exosome (RSCE™) 2023-05-19 16:34
HitGen Announces Drug Discovery Research Agreement with ARase Therapeutics 2023-05-18 21:30
Neurophet receives FDA 510(k) Clearance for Neurophet AQUA 2023-05-18 21:00
CARsgen Initiates Phase 2 Clinical Trial for CLDN18.2 CAR T-cell Product CT041 in the U.S. 2023-05-18 20:50
Asieris Deepens Strategic Partnership with UroViu to Further Develop Integrated Diagnosis and Treatment Platform for Bladder Cancer 2023-05-18 16:00
Antengene Announces Clearance of U.S. IND for the Phase I Trial of First-in-Class Anti-CD24 Monoclonal Antibody ATG-031 2023-05-18 02:47
United Imaging Unveils a Full Portfolio of Products at CMEF 2023, Highlighting Its AI Capabilities across Modalities 2023-05-17 20:00
Skyline Therapeutics Brings Multiple Data Presentations to ASGCT 2023 2023-05-17 18:00
Fresh2 Files Annual Report on Form 20-F for Fiscal Year 2022 2023-05-17 05:00
Fresh2 Reports First Quarter of Fiscal Year 2023 Financial Results 2023-05-17 04:15
Fresh2 Reports Fiscal Year 2022 Annual Financial Results 2023-05-17 04:15
Eluminex Biosciences Receives Scientific Recognition for its Recombinant Human Collagen (rhCIII) Biosynthetic Cornea (EB-301) Program to Treat Corneal Blindness 2023-05-16 23:00
1 97 98 99 100 101 812